205 related articles for article (PubMed ID: 20686046)
1. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene.
Schmeisser H; Mejido J; Balinsky CA; Morrow AN; Clark CR; Zhao T; Zoon KC
J Virol; 2010 Oct; 84(20):10671-80. PubMed ID: 20686046
[TBL] [Abstract][Full Text] [Related]
2. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
[TBL] [Abstract][Full Text] [Related]
3. Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression.
Chikhalya A; Dittmann M; Zheng Y; Sohn SY; Rice CM; Hearing P
mBio; 2021 Dec; 12(6):e0282921. PubMed ID: 34724821
[TBL] [Abstract][Full Text] [Related]
4. Protective roles of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in dengue virus infection of human lung epithelial cells.
Hsu YL; Shi SF; Wu WL; Ho LJ; Lai JH
PLoS One; 2013; 8(11):e79518. PubMed ID: 24223959
[TBL] [Abstract][Full Text] [Related]
5. The antiproliferative and antiviral activities of IFN-tau variants in human cells.
Alexenko AP; Leaman DW; Li J; Roberts RM
J Interferon Cytokine Res; 1997 Dec; 17(12):769-79. PubMed ID: 9452365
[TBL] [Abstract][Full Text] [Related]
6. Antiviral and antiproliferative activities of human leukocyte interferon potentiated by cimetidine in vitro.
Hirai N; Hill NO; Motoo Y; Osther K
J Interferon Res; 1985; 5(3):375-82. PubMed ID: 2997335
[TBL] [Abstract][Full Text] [Related]
7. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity.
Jiang Z; Su C; Zheng C
J Virol; 2016 Dec; 90(24):11056-11061. PubMed ID: 27681138
[TBL] [Abstract][Full Text] [Related]
9. Poly(I:C) inhibits porcine reproductive and respiratory syndrome virus replication in MARC-145 cells via activation of IFIT3.
Zhang L; Liu J; Bai J; Du Y; Wang X; Liu X; Jiang P
Antiviral Res; 2013 Sep; 99(3):197-206. PubMed ID: 23791982
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotype.
Niess H; Camaj P; Mair R; Renner A; Zhao Y; Jäckel C; Nelson PJ; Jauch KW; Bruns CJ
Oncotarget; 2015 Feb; 6(5):3306-18. PubMed ID: 25650658
[TBL] [Abstract][Full Text] [Related]
11. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
12. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.
Kueck T; Bloyet LM; Cassella E; Zang T; Schmidt F; Brusic V; Tekes G; Pornillos O; Whelan SPJ; Bieniasz PD
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578292
[TBL] [Abstract][Full Text] [Related]
13. The chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming.
Cui K; Tailor P; Liu H; Chen X; Ozato K; Zhao K
Mol Cell Biol; 2004 May; 24(10):4476-86. PubMed ID: 15121865
[TBL] [Abstract][Full Text] [Related]
14. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative assay of human leucocyte interferon.
Hirai N; Hattori N; Hill NO; Osther K
Tohoku J Exp Med; 1987 Mar; 151(3):309-16. PubMed ID: 3035749
[TBL] [Abstract][Full Text] [Related]
16. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
17. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential.
Alexenko AP; Ealy AD; Roberts RM
J Interferon Cytokine Res; 1999 Dec; 19(12):1335-41. PubMed ID: 10638702
[TBL] [Abstract][Full Text] [Related]
18. IFIT3 mediated the type I interferon antiviral response by targeting Senecavirus A entry, assembly and release pathways.
Xu F; Dang W; Li T; Wang Y; Yang F; Zheng H
Vet Microbiol; 2022 Dec; 275():109594. PubMed ID: 36332300
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
20. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
